178 related articles for article (PubMed ID: 9877487)
1. Selective phosphodiesterase inhibitors modulate the activity of alveolar macrophages from sensitized guinea-pigs.
Germain N; Bertin B; Legendre A; Martin B; Lagente V; Payne A; Boichot E
Eur Respir J; 1998 Dec; 12(6):1334-9. PubMed ID: 9877487
[TBL] [Abstract][Full Text] [Related]
2. Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells.
Hichami A; Boichot E; Germain N; Legrand A; Moodley I; Lagente V
Eur J Pharmacol; 1995 Oct; 291(2):91-7. PubMed ID: 8566180
[TBL] [Abstract][Full Text] [Related]
3. Effect of selective phosphodiesterase inhibitors on synaptic transmission in the guinea-pig ileum.
Izzo AA; Mascolo N; Capasso F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):677-81. PubMed ID: 9686945
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition by selective phosphodiesterase inhibitors of antigen, LTC4 and histamine-induced contraction of guinea-pig isolated trachea.
Planquois JM; Ruffin-Morin Y; Lagente V; Payne AN; Dahl SG
Pulm Pharmacol; 1996 Aug; 9(4):251-8. PubMed ID: 9160414
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration.
Danahay H; Broadley KJ
Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122
[TBL] [Abstract][Full Text] [Related]
6. Effects of SR 140333 and SR 48968 on antigen and substance P-induced activation of guinea-pig alveolar macrophages.
Boichot E; Germain N; Emonds-Alt X; Advenier C; Lagente V
Clin Exp Allergy; 1998 Oct; 28(10):1299-305. PubMed ID: 9824398
[TBL] [Abstract][Full Text] [Related]
7. The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation.
Banner KH; Moriggi E; Da Ros B; Schioppacassi G; Semeraro C; Page CP
Br J Pharmacol; 1996 Nov; 119(6):1255-61. PubMed ID: 8937731
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
Zhu WH; Majluf-Cruz A; Omburo GA
Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035
[TBL] [Abstract][Full Text] [Related]
9. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst.
Nielson CP; Vestal RE; Sturm RJ; Heaslip R
J Allergy Clin Immunol; 1990 Nov; 86(5):801-8. PubMed ID: 1977788
[TBL] [Abstract][Full Text] [Related]
11. Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors.
Wachtel H
J Neural Transm; 1983; 56(2-3):139-52. PubMed ID: 6190991
[TBL] [Abstract][Full Text] [Related]
12. Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.
Germain N; Boichot E; Planquois JM; Lagente V
Mediators Inflamm; 1999; 8(3):153-7. PubMed ID: 10704053
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
[TBL] [Abstract][Full Text] [Related]
14. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
Muller B; Lugnier C; Stoclet JC
J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs.
Santing RE; Olymulder CG; Van der Molen K; Meurs H; Zaagsma J
Eur J Pharmacol; 1995 Feb; 275(1):75-82. PubMed ID: 7774665
[TBL] [Abstract][Full Text] [Related]
17. Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
Lillestłl IK; Helle KB; Aardal S
Scand J Clin Lab Invest; 1998 Dec; 58(8):625-34. PubMed ID: 10088199
[TBL] [Abstract][Full Text] [Related]
18. In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.
Foissier L; Lonchampt M; Cogé F; Canet E
J Pharmacol Exp Ther; 1996 Sep; 278(3):1484-90. PubMed ID: 8819536
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyclic AMP analogues and phosphodiesterase inhibitors on K+-induced [3H]noradrenaline release from rat brain slices and on its presynaptic alpha-adrenergic modulation.
Wemer J; Schoffelmeer AN; Mulder AH
J Neurochem; 1982 Aug; 39(2):349-56. PubMed ID: 6283025
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
Hughes B; Howat D; Lisle H; Holbrook M; James T; Gozzard N; Blease K; Hughes P; Kingaby R; Warrellow G; Alexander R; Head J; Boyd E; Eaton M; Perry M; Wales M; Smith B; Owens R; Catterall C; Lumb S; Russell A; Allen R; Merriman M; Bloxham D; Higgs G
Br J Pharmacol; 1996 Jul; 118(5):1183-91. PubMed ID: 8818342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
